Idioma:

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines

Kim, Lindsay ; Rha, Brian ; Abramson, Jon S. ; Anderson, Larry J. ; Byington, Carrie L. ; Chen, Grace L. ; DeVincenzo, John ; Edwards, Kathryn M. ; Englund, Janet A. ; Falsey, Ann R. ; Griffin, Marie R. ; Karron, Ruth A. ; Martin, Karen G. ; Meissner, H. Cody ; Munoz, Flor M. ; Pavia, Andrew T. ; Piedra, Pedro A. ; Schaffner, William ; Simões, Eric A. F. ; Singleton, Rosalyn ; Talbot, H. Keipp ; Walsh, Edward E. ; Zucker, Jane R. ; Gerber, Susan I.

Clinical infectious diseases, 2017-09, Vol.65 (6), p.1020-1025 [Periódico revisado por pares]

United States: Oxford University Press

Texto completo disponível

Citações Citado por

Enviar para

Título:
Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines
Autor: Kim, Lindsay ; Rha, Brian ; Abramson, Jon S. ; Anderson, Larry J. ; Byington, Carrie L. ; Chen, Grace L. ; DeVincenzo, John ; Edwards, Kathryn M. ; Englund, Janet A. ; Falsey, Ann R. ; Griffin, Marie R. ; Karron, Ruth A. ; Martin, Karen G. ; Meissner, H. Cody ; Munoz, Flor M. ; Pavia, Andrew T. ; Piedra, Pedro A. ; Schaffner, William ; Simões, Eric A. F. ; Singleton, Rosalyn ; Talbot, H. Keipp ; Walsh, Edward E. ; Zucker, Jane R. ; Gerber, Susan I.
Assuntos: Adults ; Antiviral agents ; Clinical trials ; Consultation ; Cost-Benefit Analysis ; Disease control ; Epidemiology ; Humans ; Infants ; Medical research ; Monoclonal antibodies ; Older people ; Population Surveillance ; Pregnancy ; Respiratory diseases ; Respiratory syncytial virus ; Respiratory Syncytial Virus Infections - diagnosis ; Respiratory Syncytial Virus Infections - epidemiology ; Respiratory Syncytial Virus Infections - mortality ; Respiratory Syncytial Virus Infections - prevention & control ; Respiratory Syncytial Virus Vaccines - adverse effects ; Respiratory tract ; United States - epidemiology ; Vaccines ; VIEWPOINTS ; Viral infections ; Viruses ; Women
É parte de: Clinical infectious diseases, 2017-09, Vol.65 (6), p.1020-1025
Notas: ObjectType-Conference-1
SourceType-Conference Papers & Proceedings-1
content type line 25
Descrição: Respiratory syncytial virus (RSV) causes lower respiratory tract illness frequently. No effective antivirals or vaccines for RSV are approved for use in the United States; however, there are at least 50 vaccines and monoclonal antibody products in development, with those targeting older adults and pregnant women (to protect young infants) in phase 2 and 3 clinical trials. Unanswered questions regarding RSV epidemiology need to be identified and addressed prior to RSV vaccine introduction to guide the measurement of impact and future recommendations. The Centers for Disease Control and Prevention (CDC) convened a technical consultation to gather input from external subject matter experts on their individual perspectives regarding evidence gaps in current RSV epidemiology in the United States, potential studies and surveillance platforms needed to fill these gaps, and prioritizing efforts. Participants articulated their individual views, and CDC staff synthesized individuals' input into this report.
Editor: United States: Oxford University Press
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Anterior Resultado 6 Avançar Ir para próxima página

Realização: Logos de Redes Sociais:

Identifying Gaps in Respiratory Syncytial Virus Disease Epidemiology in the United States Prior to the Introduction of Vaccines

United States: Oxford University Press

Buscando em bases de dados remotas. Favor aguardar.